SCHEMBL7482184

SCHEMBL7482184

COc1ccc(F)cc1OCCCl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.47
FFAR4 Q5NUL3 1/20 0.47
HTR1A P08908 3/20 0.46
L3MBTL1 Q9Y468 5/20 0.46
TDP1 Q9NUW8 2/20 0.46
SLC6A4 P31645 4/20 0.44
DRD4 P21917 1/20 0.43
NFE2L2 Q16236 1/20 0.42
HTR2C P28335 3/20 0.40
HTR2B P41595 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
USP2 O75604 1/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HTR2A P28223 2/20 0.39
SLC6A2 P23975 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9632875 0.93 L3MBTL1 (0.46) FFAR1FFAR4HTR1AL3MBTL1TDP1
SCHEMBL19461858 0.86 L3MBTL1 (0.50) L3MBTL1TDP1NFE2L2SMN1; SMN2USP2
SCHEMBL9632496 0.84 L3MBTL1 (0.51) L3MBTL1TDP1SLC6A4HTR2CHTR2B
SCHEMBL9633169 0.84 HTR2C (0.49) L3MBTL1TDP1SLC6A4HTR2CHTR2B
SCHEMBL30990265 0.84 FFAR1 (0.51) FFAR1FFAR4HTR1AL3MBTL1TDP1
SCHEMBL18688617 0.84 PDE4D (0.50) FFAR1FFAR4HTR1AL3MBTL1TDP1
SCHEMBL9632629 0.83 L3MBTL1 (0.42) L3MBTL1TDP1HTR2CHTR2BSMN1; SMN2
SCHEMBL9462367 0.82 FFAR1 (0.47) FFAR1FFAR4HTR1AL3MBTL1TDP1
SCHEMBL7486685 0.82 TDP1 (0.50) FFAR1FFAR4HTR1AL3MBTL1TDP1
SCHEMBL4311769 0.82 HTR2C (0.55) FFAR1FFAR4HTR1AL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2042039-A None JP disclosed
EP-1068184-B1 N-ARYLOXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF DEPRESSION WYETH CORP (US) 2002-09-04 EP disclosed
US-6291683-B1 AS ANTIDEPRESSANTS AMERICAN HOME PRODUCTS CORP 2001-09-18 US disclosed
EP-1070050-A1 N-ARYLOXYETHYL-INDOLY-ALKYLAMINES FOR THE TREATMENT OF DEPRESSION (5-HT1A RECEPTOR ACTIVE AGENTS) AMERICAN HOME PRODUCTS CORPORATION (US) 2001-01-24 EP disclosed
EP-1068184-A1 N-ARYLOXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF DEPRESSION AMERICAN HOME PRODUCTS CORPORATION (US) 2001-01-17 EP disclosed
US-6121307-A SIDE EFFECT REDUCTION; ADMINISTERING TO TREAT DEPRESSION AMERICAN HOME PRODUCTS CORP. (US) 2000-09-19 US disclosed
US-6110956-A ANTIDEPRESSANTS TREATING DISORDERS OF THE SEROTONIN-AFFECTED NEUROLOGICAL SYSTEMS AMERICAN HOME PRODUCTS CORP. (US) 2000-08-29 US disclosed
WO-1999051575-A1 N-ARYLOXYETHYL-INDOLY-ALKYLAMINES FOR THE TREATMENT OF DEPRESSION (5-HT1A RECEPTOR ACTIVE AGENTS) AMERICAN HOME PRODUCTS CORPORATION (US) 1999-10-14 WO disclosed
WO-1999051576-A1 N-ARYLOXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF DEPRESSION AMERICAN HOME PRODUCTS CORPORATION (US) 1999-10-14 WO disclosed
EP-0331943-B1 PHENOXYETHYLAMINE DERIVATIVES, PROCESS FOR PREPARING THE SAME, AND COMPOSITION FOR EXHIBITING EXCELLENT ALPHA-1-BLOCKING ACTIVITY CONTAINING THE SAME Hokuriku Pharmaceutical Co.,Ltd (JP) 1992-06-17 EP disclosed
US-4971990-A HYPOTENSIVE AGENTS, DYSUREA HOKURIKU PHARMACEUTICAL CO., LTD. (JP) 1990-11-20 US disclosed
JP-H0242039-A FLUOROPHENOXYALKANE DERIVATIVE HOKURIKU SEIYAKU CO LTD 1990-02-13 JP disclosed
EP-0331943-A1 Phenoxyethylamine derivatives, process for preparing the same, and composition for exhibiting excellent alpha-1-blocking activity containing the same Hokuriku Pharmaceutical Co.,Ltd (JP) 1989-09-13 EP disclosed